The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
Popular but pricey weight-loss drugs Ozempic and Wegovy are among the 15 medications whose prices will be subject to direct negotiations between Medicare and drug makers.
In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...
Nursing home residents that receive Medicaid benefits may be affected by a change in federal poverty level standards, which are applied to eligibility ...
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The federal Centers for Medicare and Medicaid Services (CMS) approved an amendment to Vermont’s Global Commitment to Health (Global Commitment) 1115 demonstration waiver, which gives Vermont ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback